Top

Indian Journal of Thoracic and Cardiovascular Surgery

Published in:

01-12-2018 | Review Article

Myocardial revascularization: the evolution of the STS database and quality measurement for improvement

Authors: Reilly Daniel Hobbs, Gaetano Paone, Richard Salvatore D’Agostino, Jeffrey Phillip Jacobs, Donna Eileen McDonald, Richard Laurence Prager, David Michael Shahian

Published in: Indian Journal of Thoracic and Cardiovascular Surgery | Special Issue 3/2018

Abstract

The Society of Thoracic Surgeons (STS) is a not-for-profit organization dedicated to helping clinicians and researchers provide optimal outcomes for patients undergoing heart, lung, and esophageal surgery. The organization was founded in 1964 and has grown to now include over 7300 members in over 90 countries. The STS created a national database that collects detailed clinical information on patients undergoing adult cardiac, pediatric and congenital cardiac, and general thoracic operations. The data collected are used to produce risk-adjusted, nationally benchmarked performance assessments and feedback; facilitate voluntary public reporting; support quality initiatives; develop evidence-based guidelines; monitor long-term clinical outcomes; track device performance; and promote high-quality research collaboratives.

Winkley Shroyer AL, Bakaeen F, Shahian DM, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: The Driving Force for Improvement in Cardiac Surgery. Semin Thorac Cardiovasc Surg. 2015;27:144–51. https://doi.org/10.1053/j.semtcvs.2015.07.007.CrossRefPubMed

Shahian DM, Jacobs JP, Edwards FH, et al. The society of thoracic surgeons national database. Heart. 2013;99:1494–501. https://doi.org/10.1136/heartjnl-2012-303456.CrossRefPubMed

Anderson RP. First publications from The Society of Thoracic Surgeons National Database. Ann Thorac Surg. 1994;57:6–7. https://doi.org/10.1016/0003-4975(94)90355-7.CrossRefPubMed

Clark RE. It is time for a national cardiothoracic surgical data base. Ann Thorac Surg. 1989;48:755–6.CrossRefPubMed

D’Agostino RS, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 Update on Outcomes and Quality. Ann Thorac Surg. 2018;105:15–23. https://doi.org/10.1016/j.athoracsur.2017.10.035.CrossRefPubMed

Shahian DM, O’Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88:S2–22. https://doi.org/10.1016/j.athoracsur.2009.05.053. CrossRefPubMed

Shahian DM, Edwards FH. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Introduction. Ann Thorac Surg. 2009;88:S1. https://doi.org/10.1016/j.athoracsur.2009.05.054.CrossRefPubMed

O’Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 2-isolated valve surgery. Ann Thorac Surg. 2009;88:S23–42. https://doi.org/10.1016/j.athoracsur.2009.05.056.CrossRefPubMed

Vassileva CM, Aranki S, Brennan JM, et al. Evaluation of the society of thoracic surgeons online risk calculator for assessment of risk in patients presenting for aortic valve replacement after prior coronary artery bypass graft: An analysis using the STS Adult Cardiac Surgery Database. Ann. Thorac. Surg. 2015;100:2109–15. https://doi.org/10.1016/j.athoracsur.2015.04.149.CrossRefPubMed

10.

D’Agostino RS, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons adult cardiac surgery database: 2017 update on outcomes and quality. Ann Thorac Surg. 2017;103:18–24. https://doi.org/10.1016/n.athoracsur.2016.11.001.CrossRefPubMed

11.

Shahian DM, O’Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 3—valve plus coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88:S43–62. https://doi.org/10.1016/j.athoracsur.2009.05.055. CrossRefPubMed

12.

Jin R, Furnary AP, Fine SC, Blackstone EH, Grunkemeier GL. Using Society of Thoracic Surgeons risk models for risk-adjusting cardiac surgery results. Ann Thorac Surg. 2010;89:677–82. https://doi.org/10.1016/j.athoracsur.2009.10.078.CrossRefPubMed

13.

Shahian DM, Jacobs JP, Badhwar V, D’Agostino RS, Bavaria JE, Prager RL. Risk aversion and public reporting. Part 1: observations from cardiac surgery and interventional cardiology. Ann Thorac Surg. 2017;104:2093–101. https://doi.org/10.1016/j.athoracsur.2017.06.077.CrossRefPubMed

14.

Caceres M, Braud RL, Garrett HE. A short history of the Society of Thoracic Surgeons National Cardiac Database: Perceptions of a practicing surgeon. Ann Thorac Surg. 2010;89:332–9. https://doi.org/10.1016/j.athoracsur.2009.09.045.CrossRefPubMed

15.

Ferris TG, Torchiana DF. Public release of clinical outcomes data—online CABG report cards. N Engl J Med. 2010;363:1593–5. https://doi.org/10.1056/NEJMp1009423.CrossRefPubMed

16.

Mariscalco G, Engström KG. Atrial fibrillation after cardiac surgery: Risk factors and their temporal relationship in prophylactic drug strategy decision. Int J Cardiol. 2008;129:354–62. https://doi.org/10.1016/j.ijcard.2007.07.123.CrossRefPubMed

17.

Bramer S, van Straten AHM, Soliman Hamad MA, Berreklouw E, Martens EJ, Maessen JG. The impact of preoperative atrial fibrillation on early and late mortality after coronary artery bypass grafting. Eur J Cardio-Thoracic Surg. 2010;38:373–9. https://doi.org/10.1016/j.ejcts.2010.02.017.CrossRef

18.

Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: A meta-analysis. Eur Heart J. 2006;27:2846–57. https://doi.org/10.1093/eurheartj/ehl272.CrossRefPubMed

19.

Kulik A, Ruel M, Jneid H, Ferguson TB, et al. Secondary prevention after coronary artery bypass graft surgery: A scientific statement from the American Heart Association. Circulation. 2015;131:927–64. https://doi.org/10.1161/CIR.0000000000000182.CrossRefPubMed

20.

Brinkman W, Herbert MA, O’Brien S, et al. Preoperative β-Blocker use in coronary artery bypass grafting surgery.national database analysis. JAMA Intern Med. 2014;174:1320–7. https://doi.org/10.1001/jamainternmed.2014.2356. CrossRefPubMed

21.

LaPar DJ, Crosby IK, Kron IL, et al. Preoperative beta-blocker use should not be a quality metric for coronary artery bypass grafting. Ann Thorac Surg. 2013;96:1539–44.CrossRefPubMed

22.

Shahian DM. Preoperative β-blockade in coronary artery bypass grafting surgery. JAMA Intern Med. 2014;174:1328–9.CrossRefPubMed

23.

Sun C, Zhang H, Zheng Z. Efficacy of β-blocker therapy for secondary prevention for patients undergoing coronary artery bypass grafting surgery. Curr Opin Cardiol. 2016;31:654–61.CrossRefPubMed

24.

Ferguson TB, Coombs LP, Peterson ED. Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002;287:2221–7.CrossRefPubMed

25.

Chan AYM, McAlister FA, Norris CM, Johnstone D, Bakal JA, Ross DB. Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery. J Thorac Cardiovasc Surg. 2010;140:182–7.CrossRefPubMed

26.

Zeinah M, Elghanam M, Benedetto U. Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treatment benefit-risk meta-analysis. Egypt Hear J. 2016;68:89–96.CrossRef

27.

Foody JM, Ferdinand FD, Galusha D, et al. Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction. Circulation. 2003;108:24–8.CrossRef

28.

Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2014;129:S49–73. https://doi.org/10.1161/01.cir.0000437741.48606.98.CrossRef

29.

Kulik A, Brookhart MA, Levin R, Ruel M, Solomon DH, Choudhry NK. Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation. 2008;118:1785–92. https://doi.org/10.1161/CIRCULATIONAHA.108.799445.CrossRefPubMed

30.

Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110:II45–I49.PubMed

31.

Campeau L. Lipid lowering and coronary bypass graft surgery. Curr Opin Cardiol. 2000;15:395–9.CrossRefPubMed

32.

Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation. 1998;97:916–31.CrossRefPubMed

33.

Investigators TPCABGT. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med. 1997;336:153–62.CrossRef

34.

Abramov D, Tamariz MG, Sever JY, et al. The influence of gender on the outcome of coronary artery bypass surgery. Ann Thorac Surg. 2000;70:800–5.CrossRefPubMed

35.

Cohn L. Use of the internal mammary artery graft and in-hospital mortality and other adverse outcomes associated with coronary artery bypass surgery. Circulation. 2001;103:483–4.CrossRefPubMed

36.

Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1–6.CrossRefPubMed

37.

Engelman DT, Cohn LH, Rizzo RJ. Incidence and predictors of TIAs and strokes following coronary artery bypass grafting: report and collective review. Heart Surg Forum. 1999;2:242–5.PubMed

38.

Puskas JD, Winston AD, Wright CE, et al. Stroke after coronary artery operation: Incidence, correlates, outcome, and cost. Ann Thorac Surg. 2000;69:1053–6.CrossRefPubMed

39.

Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75:1856–64.CrossRefPubMed

40.

Welke KF, Ferguson TB, Coombs LP, et al. Validity of the Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Ann Thorac Surg. 2004;77:1137–9.CrossRefPubMed

41.

Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg. 2004;78:527–34.CrossRefPubMed

42.

Mehta RH, Sheng S, O’Brien SM, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: Incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes. 2009;2:583–90. https://doi.org/10.1161/CIRCOUTCOMES.109.858811.CrossRefPubMed

43.

Olsen MA, Lock-Buckley P, Hopkins D, Polish LB, Sundt TM, Fraser VJ. The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg. 2002;124:136–45. https://doi.org/10.1067/mtc.2002.122306.CrossRefPubMed

44.

Kubota H, Miyata H, Motomura N, et al. Deep sternal wound infection after cardiac surgery. J Cardiothorac Surg. 2013;8:132. https://doi.org/10.1186/1749-8090-8-132.CrossRefPubMedPubMedCentral

45.

Tang GH, Maganti M, Weisel RD, Borger MA. Prevention and management of deep sternal wound infection. Semin Thorac Cardiovasc Surg. 2004;16:62–9.CrossRefPubMed

46.

Braxton JH, Marrin CAS, McGrath PD, et al. 10-Year follow-up of patients with and without mediastinitis. Semin Thorac Cardiovasc Surg. 2004;16:70–6. https://doi.org/10.1053/j.semtcvs.2004.01.006.CrossRefPubMed

47.

Conlon PJ, Stafford-Smith M, White WD, et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999;14:1158–62.CrossRefPubMed

48.

Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343–8.CrossRefPubMed

49.

Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998;128:194–203.CrossRefPubMed

50.

Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney Injury: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2009;53:961–73. https://doi.org/10.1053/j.ajkd.2008.11.034.CrossRefPubMedPubMedCentral

51.

Naughton C, Reilly N, Powroznyk A, et al. Factors determining the duration of tracheal intubation in cardiac surgery: A single-centre sequential patient audit. Eur J Anaesthesiol. 2003;20:225–33.CrossRefPubMed

52.

Speir AM, Kasirajan V, Barnett SD, Fonner E. Additive costs of postoperative complications for isolated coronary artery bypass grafting patients in Virginia. Ann Thorac Surg. 2009;88:40–6. https://doi.org/10.1016/j.athoracsur.2009.03.076.CrossRefPubMed

53.

Brown PP, Kugelmass AD, Cohen DJ, et al. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg. 2008;85:1980–6.CrossRefPubMed

54.

Engelman R, Shahian D, Shemin R, et al. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. AnnThorac Surg. 2007;83:1569–76.CrossRef

55.

Austin TW, Coles JC, Burnett R, Goldbach M. Aortocoronary bypass procedures and sternotomy infections: A study of antistaphylococcal prophylaxis. Can J Surg. 1980;23:483–5.PubMed

56.

Buxton BF, Shi WY, Tatoulis J, Fuller JA, Rosalion A, Hayward PA. Total arterial revascularization with internal thoracic and radial artery grafts in triple-vessel coronary artery disease is associated with improved survival. J Thorac Cardiovasc Surg. 2014;148:1238–43. https://doi.org/10.1016/j.jtcvs.2014.06.056.CrossRefPubMed

57.

Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH. Late Results of Conventional Versus All-Arterial Revascularization Based on Internal Thoracic and Radial Artery Grafting. Ann Thorac Surg. 2009;87:19–26. https://doi.org/10.1016/j.athoracsur.2008.09.050.CrossRefPubMed

58.

Gaudino M, Benedetto U, Fremes S, et al. Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery. N Engl J Med. 2018;378:2069–77. https://doi.org/10.1056/NEJMoa1716026.CrossRefPubMed

59.

Aldea GS, Bakaeen FG, Pal J, et al. The Society of Thoracic Surgeons clinical practice guidelines on arterial conduits for coronary artery bypass grafting. Ann Thorac Surg. 2016;101:801–9.CrossRefPubMed

Title: Myocardial revascularization: the evolution of the STS database and quality measurement for improvement
Authors: Reilly Daniel Hobbs
Gaetano Paone
Richard Salvatore D’Agostino
Jeffrey Phillip Jacobs
Donna Eileen McDonald
Richard Laurence Prager
David Michael Shahian
Publication date: 01-12-2018
Publisher: Springer Singapore
Published in: Indian Journal of Thoracic and Cardiovascular Surgery / Issue Special Issue 3/2018
Print ISSN: 0970-9134
Electronic ISSN: 0973-7723
DOI: https://doi.org/10.1007/s12055-018-0726-z

At a glance: The STEP trials

Springer Medicine

Myocardial revascularization: the evolution of the STS database and quality measurement for improvement

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 3/2018

Current role of saphenous vein graft in coronary artery bypass grafting

Transmyocardial revascularization (TMR): current status and future directions

Off-pump versus on-pump coronary artery bypass grafting—a surreal controversy?

The effect of storage solutions on endothelial function and saphenous vein graft patency

Genetics, coronary artery disease, and myocardial revascularization: will novel genetic risk scores bring new answers?

Saphenous vein: advances